Intervacc intervacc.se


Intervacc (NASDAQ Stockholm: IVACC) is a Swedish company active in the biotechnology sector. The company's veterinary vaccines, such as Strangvac, are based on recombinant proteins, to meet the increasing need for effective vaccines in animal health care.

Intervacc (NASDAQ Stockholm: IVACC) is a Swedish company active in the biotechnology sector. The company's veterinary vaccines, such as Strangvac, are based on recombinant proteins, to meet the increasing need for effective vaccines in animal health ...Show all

Company (IPO / Went public)

Phone: +46 08-120 10 600

Fax:

Vaestertorpsvaegen 135

Hagersten, SE-129 44
Sweden

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Intervacc $0M Apr 7, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Intervacc Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Vaccine against streptococcal infections based on recombinant proteins Dec 04, 2015 Oct 24, 2017 Patent
Vaccine against streptococcal infections based on recombinant proteins May 25, 2011 May 10, 2016 Patent
Immunization of non-human mammals against Oct 10, 2003 Mar 26, 2013 Patent
Immunizing composition May 13, 2013 Application